GSK2838504A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2838504A, covering 2018-08-01 to 2018-08-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction. [Phase 2]